Clinical trial
Treatment of Childhood Acute Lymphoblastic Leukemia
NCT00165087 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Childhood Acute Lymphoblastic Leukemia
- Lead sponsor
- Dana-Farber Cancer Institute
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- January 31, 1996
- Completion date
- September 30, 2006
- Enrollment
- 491
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
acute lymphoblastic leukemia